Tombal B - Search Results

1

Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases.

Tombal B, Rezazadeh A, Therasse P, Van Cangh PJ, Vande Berg B, Lecouvet FE. Tombal B, et al. Prostate. 2005 Oct 1;65(2):178-87. doi: 10.1002/pros.20280. Prostate. 2005. PMID: 15948151 Clinical Trial.

2

[Role of intracellular calcium in the programmed cell death of prostatic cancer cells].

Tombal B, Gailly P, Van Cangh PJ, Gillis JM. Tombal B, et al. Acta Urol Belg. 1995 Mar;63(1):1-5. Acta Urol Belg. 1995. PMID: 7537010 French.

3

[Epipadiac duplication of the urethra].

Mostin J, Tombal B, Keupens F, Opsomer R, Clapuyt P, Van Nieuwenhuis JP, Lorge F, Veyckemans F, Van Cangh P, Wese FX. Mostin J, et al. Among authors: tombal b. Acta Urol Belg. 1995 Mar;63(1):37-42. Acta Urol Belg. 1995. PMID: 7725991 French.

4

Vessels around the ureteropelvic junction: significance and imaging by conventional radiology.

Van Cangh PJ, Nesa S, Galeon M, Tombal B, Wese FX, Dardenne AN, Opsomer R, Lorge F. Van Cangh PJ, et al. Among authors: tombal b. J Endourol. 1996 Apr;10(2):111-9. doi: 10.1089/end.1996.10.111. J Endourol. 1996. PMID: 8728675

5

Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.

Van Cangh PJ, De Nayer P, Sauvage P, Tombal B, Elsen M, Lorge F, Opsomer R, Wese FX. Van Cangh PJ, et al. Among authors: tombal b. Prostate Suppl. 1996;7:30-4. Prostate Suppl. 1996. PMID: 8950361

6

Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA.

Van Cangh PJ, De Nayer P, De Vischer L, Sauvage P, Tombal B, Lorge F, Wese FX, Opsomer R. Van Cangh PJ, et al. Among authors: tombal b. Urology. 1996 Dec;48(6A Suppl):67-70. doi: 10.1016/s0090-4295(96)00613-9. Urology. 1996. PMID: 8973703

7

Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization.

Gala JL, Heusterspreute M, Loric S, Hanon F, Tombal B, Van Cangh P, De Nayer P, Philippe M. Gala JL, et al. Among authors: tombal b. Clin Chem. 1998 Mar;44(3):472-81. Clin Chem. 1998. PMID: 9510850

8

Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers.

Tombal B, De Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, Van Cangh PJ. Tombal B, et al. BJU Int. 1999 Dec;84(9):1015-20. doi: 10.1046/j.1464-410x.1999.00386.x. BJU Int. 1999. PMID: 10571626

9

Intermittent endocrine treatment.

Van Cangh PJ, Tombal B, Gala JL. Van Cangh PJ, et al. Among authors: tombal b. World J Urol. 2000 Jun;18(3):183-9. doi: 10.1007/s003459900101. World J Urol. 2000. PMID: 10926082 Review.

10

Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?

Gala JL, Loric S, Guiot Y, Denmeade SR, Gady A, Brasseur F, Heusterspreute M, Eschwège P, De Nayer P, Van Cangh P, Tombal B. Gala JL, et al. Among authors: tombal b. Clin Cancer Res. 2000 Oct;6(10):4049-54. Clin Cancer Res. 2000. PMID: 11051255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page